Recursion Pharmaceuticals, Inc. (RXRX) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Snapshot as of Apr 24, 2026.
- Spot Price
- $3.51
- ATM IV
- 83.0%
- IV Skew 25Δ
- 0.185
- IV Rank
- 22.0%
- IV Percentile
- 25.0%
- Term Structure Slope
- -0.019
As of Apr 24, 2026, Recursion Pharmaceuticals, Inc. (RXRX) at-the-money implied volatility is 83.0%. IV rank is 22.0% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 25.0%. The 25-delta skew is +0.185 — calls carry premium over puts, indicating upside speculation or squeeze risk. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.